20622-7 |
Cortisol |
MCnc |
Urine |
24H |
Qn |
|
|
ACTIVE |
Cortisol [Mass/volume] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHEM |
|
20622-7 |
|
|
|
|
Both |
|
|
|
0 |
Cortis 24h Ur-mCnc |
|
|
|
Y |
|
1 day; 17-Hydroxycorticosterone; 24 hours; 24HR; Chemistry; Compound F; Coritsol; Cort; Endocrine; Endocrinology; F; hydrocortisone; Level; Mass concentration; QNT; Quan; Quant; Quantitative; UA; UR; Urn |
2.73 |
1.0m |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
20623-5 |
Coproporphyrin |
MCnc |
Urine |
24H |
Qn |
|
|
ACTIVE |
Coproporphyrin [Mass/volume] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
CHEM |
|
20623-5 |
|
|
|
|
Observation |
|
|
|
0 |
Copro 24h Ur-mCnc |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Chemistry; Copro; Coproporph; Coproporphyrins; Hematology; Heme; Level; Mass concentration; QNT; Quan; Quant; Quantitative; Tetracarboxyl porphyrin; Tetracarboxylporphyrin; Tetracarboxylporphyrins; Tetracarboxyporphyrin; UA; UR; Urn |
2.73 |
1.0m |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
20624-3 |
Creatinine |
MCnc |
Urine |
24H |
Qn |
|
|
ACTIVE |
Creatinine [Mass/volume] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
g/L; mcg/mL; mg/dL; mg/mL |
|
|
|
|
|
|
CHEM |
|
20624-3 |
|
|
|
|
Both |
|
|
|
0 |
Creat 24h Ur-mCnc |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Kidney; Level; Mass concentration; Nephrology; QNT; Quan; Quant; Quantitative; Renal; UA; UCr; UniversalLabOrders; UR; Urn |
2.73 |
1.0m |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
20625-0 |
Lead |
MCnc |
Urine |
24H |
Qn |
|
|
ACTIVE |
Lead [Mass/volume] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20625-0 |
|
|
|
|
Both |
|
|
|
0 |
Lead 24h Ur-mCnc |
|
|
|
Y |
|
1 day; 24 hours; 24HR; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Painter's colic; PB; Plumbism; QNT; Quan; Quant; Quantitative; UA; UR; Urn |
2.73 |
1.0m |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
20626-8 |
Reducing substances |
ACnc |
Urine |
Pt |
SemiQn |
Test strip |
|
ACTIVE |
Reducing substances [Units/volume] in Urine by Test strip |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
UA |
|
20626-8 |
|
Test strip |
|
|
Observation |
|
|
|
0 |
Reducing Subs Ur Strip-aCnc |
|
|
|
Y |
|
Arbitrary concentration; Dip stick; Dipstick; Point in time; Random; Reduc; Reduc subs; Reducing substance; SmQn; UA; UR; URINALYSIS; Urn |
2.75 |
1.0m |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
20627-6 |
Turbidity |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Turbidity [Presence] of Urine Qualitative |
|
MIN |
DefinitionDescription |
|
|
|
Clear; Slightly cloudy; Cloudy |
|
|
|
|
|
SPEC |
|
20627-6 |
|
|
|
|
Observation |
|
|
|
0 |
Turbidity Ur Ql |
|
|
|
|
|
Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SPEC; UA; UR; Urn |
2.73 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20628-4 |
Blasts.terminal deoxyribonucleotidyl transferase/Blasts |
NFr |
XXX |
Pt |
Qn |
Immunoperoxidase stain |
|
ACTIVE |
Terminal Deoxyribonucleotidyl Transferase blasts/Blasts in Specimen by Immunoperoxidase stain |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CELLMARK |
|
20628-4 |
|
Immunoperoxidase stain |
|
|
Observation |
|
|
|
0 |
TdT Blasts/Blasts NFr Spec IP Stn |
|
|
|
Y |
|
Blast; CELL MARKERS; Immunoperox; IP stain; IP Stn; Misc; Miscellaneous; Number fraction; Other; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; St; Stains; Stn; TdT; TdT Blasts; To be specified in another part of the message; Unspecified |
2.79 |
1.0m |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
20629-2 |
levoFLOXacin |
Susc |
Isolate |
Pt |
OrdQn |
|
|
ACTIVE |
levoFLOXacin [Susceptibility] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
20629-2 |
|
|
|
|
Observation |
|
|
|
0 |
levoFLOXacin Susc Islt |
|
|
|
|
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.73 |
1.0m |
|
|
|
|
|
|
|
|
|
|
|
0 |
2063-6 |
Cerebroside sulfatase |
CCnc |
WBC |
Pt |
Qn |
|
|
ACTIVE |
Cerebroside sulfatase [Enzymatic activity/volume] in Leukocytes |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
2063-6 |
|
|
|
|
Both |
|
|
|
0 |
Arylsulfatase A WBC-cCnc |
|
|
|
Y |
|
Aryl sulfatase A; Arylsulfatase A; Catalytic Concentration; Chemistry; Leukocytes; Metachromatic leucodystrophy; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells |
2.73 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
20631-8 |
Lymphocytes.activated T cells/Lymphocytes.small |
NFr |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Activated T cells lymphocytes/Lymphocytes.small in Blood |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CELLMARK |
|
20631-8 |
|
|
|
|
Observation |
|
|
|
0 |
Activ T Lymphs NFr Bld |
|
|
|
Y |
|
Activ; Activ T Lymphs; Blood; Cell; CELL MARKERS; Cellularity; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T prime; WB; Whole blood |
2.79 |
1.0m |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
20632-6 |
Lymphocytes.activated T cells/Lymphocytes.small |
NFr |
XXX |
Pt |
Qn |
|
|
ACTIVE |
Activated T cells lymphocytes/Lymphocytes.small in Specimen |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CELLMARK |
|
20632-6 |
|
|
|
|
Observation |
|
|
|
0 |
Activ T Lymphs NFr Spec |
|
|
|
Y |
|
Activ; Activ T Lymphs; Cell; CELL MARKERS; Cellularity; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Misc; Miscellaneous; Number fraction; Other; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; T prime; To be specified in another part of the message; Unspecified |
2.79 |
1.0m |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
20633-4 |
1-Methylhistidine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
1-Methylhistidine [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mcmol/dL; mcmol/L; umol/L |
|
|
|
|
|
|
CHEM |
|
20633-4 |
|
|
|
|
Observation |
|
|
|
0 |
1Me-hist SerPl-sCnc |
|
|
|
Y |
|
1Me-hist; Chemistry; i; Level; methyl-histidine; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0m |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
20634-2 |
Alpha aminobutyrate |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Alpha aminobutyrate [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mcmol/dL; mcmol/L; umol/L |
|
|
|
|
|
|
CHEM |
|
20634-2 |
|
|
|
|
Observation |
|
|
|
0 |
A-Aminobutyr SerPl-sCnc |
|
|
|
Y |
|
2-aminobutanoic acid; 2-aminobutyrate; 2-aminobutyric acid; A-Aminobutyr; AANB; A-ANB; Alfa; Alpha aminobutyric acid; Alpha amino-n-butyrate; Alpha amino-n-butyric acid; Aminobutric; Aminobutyric; Amino-n-butyrate; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0m |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
20635-9 |
3-Methylhistidine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
3-Methylhistidine [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mcmol/dL; mcmol/L; umol/L |
|
|
|
|
|
|
CHEM |
|
20635-9 |
|
|
|
|
Observation |
|
|
|
0 |
3Me-histidine SerPl-sCnc |
|
|
|
Y |
|
3Me-histidine; 3-MH; Ch3hist; Chemistry; III; Level; methyl-histidine; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0m |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
20636-7 |
Alanine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Alanine [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mcmol/dL; mcmol/L; umol/L |
|
|
|
|
|
|
CHEM |
|
20636-7 |
|
|
|
|
Observation |
|
|
|
0 |
Alanine SerPl-sCnc |
|
|
|
Y |
|
Ala; Alpha alanine; Chemistry; L-alanine; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0m |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
20637-5 |
Arginine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Arginine [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mcmol/dL; mcmol/L; umol/L |
|
|
|
|
|
|
CHEM |
|
20637-5 |
|
|
|
|
Observation |
|
|
|
0 |
Arginine SerPl-sCnc |
|
|
|
Y |
|
Arg; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0m |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
20638-3 |
Asparagine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Asparagine [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mcmol/dL; mcmol/L; umol/L |
|
|
|
|
|
|
CHEM |
|
20638-3 |
|
|
|
|
Observation |
|
|
|
0 |
Asparagine SerPl-sCnc |
|
|
|
Y |
|
Asn; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0m |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
20639-1 |
Aspartate |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Aspartate [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mcmol/dL; mcmol/L; umol/L |
|
|
|
|
|
|
CHEM |
|
20639-1 |
|
|
|
|
Observation |
|
|
|
0 |
Aspartate SerPl-sCnc |
|
|
|
Y |
|
Asp; Aspartic acid; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0m |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
2064-4 |
Ceruloplasmin |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Ceruloplasmin [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mg/L;mg/dL |
|
|
|
|
|
|
CHEM |
|
2064-4 |
|
|
|
|
Both |
|
|
|
0 |
Ceruloplasmin SerPl-mCnc |
|
|
|
Y |
|
Caeruloplasmin; Chemistry; Copper oxidase; Cp; Ferroxidase; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders |
2.73 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
20640-9 |
Citrulline |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Citrulline [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mcmol/dL; mcmol/L; umol/L |
|
|
|
|
|
|
CHEM |
|
20640-9 |
|
|
|
|
Both |
|
|
|
0 |
Citrulline SerPl-sCnc |
|
|
|
Y |
|
Chemistry; CIT; Citr; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; UniversalLabOrders |
2.73 |
1.0m |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
20641-7 |
Cysteine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cysteine [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
20641-7 |
|
|
|
|
Observation |
|
|
|
0 |
Cysteine SerPl-sCnc |
|
|
|
Y |
|
Chemistry; Cys; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.7 |
1.0m |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
20642-5 |
Glutamate |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glutamate [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mcmol/dL; mcmol/L; umol/L |
|
|
|
|
|
|
CHEM |
|
20642-5 |
|
|
|
|
Observation |
|
|
|
0 |
Glutamate SerPl-sCnc |
|
|
|
Y |
|
c707; Chemistry; Glu; Glutamic acid; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0m |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
20643-3 |
Glutamine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glutamine [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mcmol/dL; mcmol/L; umol/L |
|
|
|
|
|
|
CHEM |
|
20643-3 |
|
|
|
|
Observation |
|
|
|
0 |
Glutamine SerPl-sCnc |
|
|
|
Y |
|
Chemistry; Gln; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0m |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
20644-1 |
Glycine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glycine [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mcmol/dL; mcmol/L; umol/L |
|
|
|
|
|
|
CHEM |
|
20644-1 |
|
|
|
|
Observation |
|
|
|
0 |
Glycine SerPl-sCnc |
|
|
|
Y |
|
Chemistry; Gly; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0m |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
20645-8 |
Histidine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Histidine [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mcmol/dL; mcmol/L; umol/L |
|
|
|
|
|
|
CHEM |
|
20645-8 |
|
|
|
|
Observation |
|
|
|
0 |
Histidine SerPl-sCnc |
|
|
|
Y |
|
Chemistry; Formiminoglutamic Acidemia; His; Histidinemia; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0m |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |